Regadenoson is safe, effective for use in heart transplant patients
Sunday, March 14, 2010 - 10:07
in Health & Medicine
The drug regadenoson is safe and poses fewer side effects than the conventional medication used during a cardiac nuclear stress test of heart transplant patients, according to a Henry Ford Hospital study.
Read the whole article on Physorg
More from Physorg
Related
- Regadenoson is safe, effective for use in heart transplant patientsSun, 14 Mar 2010, 10:16:41 EDT
- Non-cardiac surgery: Safe for patients with heart deviceFri, 15 Apr 2011, 14:03:53 EDT
- Heart transplant surgery safe and effective: A Canadian retrospective spanning 3 decades Mon, 24 Oct 2011, 12:36:06 EDT
- Henry Ford Hospital: New left-side heart pump improves right-side heart functionThu, 27 May 2010, 9:34:40 EDT
- Henry Ford Hospital study: Fewer infections with new heart-pump implantThu, 27 May 2010, 9:35:19 EDT